share_log

吉林敖东(000623.SZ):业务范围涵盖中成药、中药配方颗粒、中药饮片、化学药品等

Jilin Aodong Pharmaceutical Group (000623.SZ): The scope of business covers Chinese Patent Medicine, Traditional Chinese Medicine granules, Traditional Chinese Medicine pieces, Chemical Drug, and so on.

Gelonghui Finance ·  Jan 9 03:21

On January 9, Gelonghui reported that Jilin Aodong Pharmaceutical Group (000623.SZ) stated on the investor interaction platform that the company belongs to the pharmaceutical manufacturing industry and is mainly engaged in the research and development, manufacturing, and sales of Traditional Chinese Medicine and Chemical Drugs. Currently, the company's business scope includes Chinese Patent Medicine, Traditional Chinese Medicine formula granules, Traditional Chinese Medicine slices, and Chemical Drugs, while also actively expanding into health food, food, breeding, and planting fields, gradually forming a "pharmaceutical + finance + big health" multi-wheel driving development model. With the national continuous promotion of ice and snow economic vitality, the northeastern ice and snow tourism is booming, and the company will fully leverage the popularity of ice and snow tourism for product marketing, increase publicity efforts, and enhance the Aodong brand influence.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment